EPISODE · Dec 12, 2022 · 10 MIN
Competition is coming for a top drug
from POLITICO's Pulse Check · host POLITICO
Today in our Pulse Check podcast, Lauren Gardner talks with Megan Messerly about the introduction of biosimilars next year to compete with Humira, the anti-inflammatory used to treat arthritis that has been the best-selling drug in America. Competition could reduce prices for consumers, but that’s not certain. Lauren explains how it could play out. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Today in our Pulse Check podcast, Lauren Gardner talks with Megan Messerly about the introduction of biosimilars next year to compete with Humira, the anti-inflammatory used to treat arthritis that has been the best-selling drug in America. Competition could reduce prices for consumers, but that’s not certain. Lauren explains how it could play out. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Competition is coming for a top drug
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 14, 2026 ·2m